Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 60 resultados

CAARE: Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy The Doctoral Network CAARE - Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy focuses on a rapidly em...
2024-06-25 - 2028-09-30 | Financiado

ORGESTRA: Organoid technologies for disease modeling, drug discovery and development for rare diseases INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 The vast majority of rare diseases are characterized by genetic origin, often severe in pathology and with limited or no treatment options....
2023-07-11 - 2027-12-31 | Financiado

CARxALL: Next generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-... INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 R/R T-ALL remains a major clinical challenge. Despite improved survival rates thanks to intensive chemotherapy regimens, event-free (EFS) an...
2023-03-13 - 2026-03-31 | Financiado

ISIDORe: Integrated Services for Infectious Disease Outbreak Research INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado

ARDAT: Accelerating Research Development for Advanced Therapies INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage Major current hurdles for wide clinical use of AAV vectors are attributable primarily to: (i) host elimination by both immune and non-immune...
2020-11-11 - 2025-10-31 | Financiado

TRANSVAC-DS: DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-SC5-2018-2019-2020 The TRANSVAC-DS project further builds on the outstanding success of EC-funded projects:TRANSVAC1 and TRANSVAC2 and proposes the establishme...
2020-06-09 - 2023-02-28 | Financiado

PURE: Precisely Patterned Nanofibers for High Performance Bioseparations INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-FETOPEN-2018-2020 Biopharmaceutical drugs save lives and drastically improve well-being. The number of new bio-drugs approved or in pipeline is rising but onl...
2020-05-26 - 2025-03-31 | Financiado

ADDovenom: ADDovenom Novel Snakebite Therapy Platform of Unparalleled Efficacy Safety and Affordability INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-FETOPEN-2018-2020 ADDovenom initiates a major multidisciplinary effort to achieve a timely step-change in snakebite therapy, by creating an innovative platfor...
2020-05-26 - 2025-03-31 | Financiado

MULTI-STR3AM: A sustainable multi strain multi method multi product microalgae biorefinery integrating industria... INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-BBI-JTI-2019 MULTI-STR3AM is driven by a critical need to shift to a sustainable means of producing food, feed and raw materials. Microalgae represent a...
2020-04-29 - 2025-04-30 | Financiado

SEArcularMINE: Circular Processing of Seawater Brines from Saltworks for Recovery of Valuable Raw Materials INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-SC5-2018-2019-2020 In this proposal, we build on the ancient and still widely used process of saltworks, where seawater goes through natural evaporation and fr...
2020-04-16 - 2024-08-31 | Financiado

BRAV3: Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative bio... INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-SC1-BHC-2018-2020 Ischemic heart disease is the main cause of death in the EU, straining patients and economies. Regenerative Medicine has failed at deliverin...
2019-12-06 - 2024-12-31 | Financiado

BioICEP: Bio Innovation of a Circular Economy for Plastics INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-NMBP-TR-IND-2018-2020 The Bio Innovation of a Circular Economy for Plastics (BioICEP) is a pan European-Chinese collaboration formed to reduce the burden of plast...
2019-10-11 - 2024-06-30 | Financiado

CRUZIVAX: Vaccine for prevention and treatment of Trypanosoma cruzi infection INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-SC1-BHC-2018-2020 Chagas is a neglected disease endemic in 21 Latin-American countries caused by Trypanosoma cruzi. It is the largest parasitic disease burden...
2019-04-30 - 2025-02-28 | Financiado

LIMBo: Zooming the link between diet and brain health how phenolic metabolites modulate brain inflammation INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: ERC-2018-STG Currently a big concern of our aging society is to efficiently delay the onset of neurodegenerative diseases which are progressively rising...
2018-12-17 - 2025-09-30 | Financiado

ProMeTeus: Membrane protein integrated technologies development for drug design INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-MSCA-RISE-2018 The aim of the ProMeTeus Consortium is to provide high-quality multidisciplinary knowledge through training and research on the development...
2018-10-04 - 2023-12-31 | Financiado

STACCATO: European Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process develop... INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-MSCA-ITN-2018 Our ability to utilise biological systems to produce medicines has improved the quality of life for millions of EU citizens. In recent years...
2018-08-24 - 2022-12-31 | Financiado

GLOPACK: Granting society with LOw environmental impact innovative PACKaging INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-SFS-2016-2017 GLOPACK proposes a cutting-edge strategy addressing the technical and societal barriers to spread in our social system, innovative eco-effic...
2018-05-04 - 2021-11-30 | Financiado

StemCellHabitat: Metabolic and Timed Control of Stem Cell Fate in the Developing Animal INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: ERC-2017-STG Stem cell (SC) proliferation during development requires tight spatial and temporal regulation to ensure correct cell number and right cell...
2017-12-19 - 2024-07-31 | Financiado

CHIC: Chicory as a multipurpose crop for dietary fibre and medicinal terpenes INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-NMBP-2016-2017 CHIC is the Chicory Innovation Consortium. Its objective is 1) to implement New Plant Breeding Techniques (NPBTs) in chicory in order to est...
2017-11-07 - 2022-12-31 | Financiado

IT-DED3: Integrated Training in Dry Eye Disease Drug Development IT DED3 INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA participó en un H2020: H2020-MSCA-ITN-2017 The European network for Integrated Training in Dry Eye Disease Drug Development (IT-DED3) aims to deliver multidisciplinary and entrepreneu...
2017-08-17 - 2022-08-31 | Financiado

IBET